Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 118.72
1.03 %
$ 11.8 B
Market Cap
36.09
P/E
NBIX - LONG-TERM DEBT
Long-term Debt NBIX - Neurocrine Biosciences, Inc.
455 M
LAST VALUE
120.62%
2 YEAR CAGR
39.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR